The Moscone Center
San Francisco, California, United States
1 - 6 February 2020
Conference BO101
Therapeutics and Diagnostics in Urology 2020
Saturday 1 February 2020
This conference is no longer accepting submissions.
Late submissions may be considered subject to chair approval. For more information, please contact Annie Gerstl.
Important
Dates
show | hide
Abstract Due:
24 July 2019

Author Notification:
30 September 2019

Manuscript Due Date:
8 January 2020

Conference
Cosponsors
Conference
Committee
show | hide
Conference Chair
Program Committee
Program Committee continued...
Call for
Papers
SPECIAL ABSTRACT REQUIREMENTS
Submissions to this conference must include:
  • 100-word text abstract (for online program)
  • 250-word text abstract (for abstract digest)
  • 2-page extended abstract (for committee review only). The extended abstract must be submitted as a separate PDF document limited to two pages, including tables and figures. Include author names and affiliations; text; any figures, tables, or images; and sufficient data to permit committee review.


  • This era of high technology in urology includes many new and routine uses of lasers for treatment and diagnosis. In addition, the use of light for both phototherapeutic and photodiagnostic purposes continues to move from research lab to clinical use. Laser applications assisted with robotic devices enable high precision tissue cutting and ablation during surgery. Other energy-based treatments are also being applied for selective tissue destruction in urology.

    This conference covers the use of lasers and thermal technology for treatment and diagnosis in urology and provides an opportunity to share ideas and technical information among scientists, engineers, and clinicians.

    Papers are solicited in urological applications of therapeutic and diagnostic modalities including, but not limited to, the following:

    Lasers for phototherapeutics
  • Fundamental laser-cell/tissue interactions in urological applications
  • Laser coagulation/ablation/resection of tumors in bladder, kidney, ureter, and renal pelvis
  • Photodynamic therapy of upper and lower urinary tracts
  • Lithotripsy with lasers, shockwave, high-intensity focused ultrasound (HIFU), and pneumatic systems

    Other energy forms for tissue treatment
  • Minimally invasive surgical techniques including radio frequency, microwave, HIFU, cryo, plasma, and irreversible electroporation (IRE)
  • Tissue treatment effects and healing responses after energy-based treatments

    Tissue imaging for diagnostics
  • Cellular/molecular imaging, probing, and optical biopsy in urology
  • Pre-clinical/clinical applications of optical imaging including optical coherence tomography (OCT), photoacoustic tomography (PAT), fluorescence, polarization, confocal, spectroscopy, microscopy, and photodynamic diagnosis (PDD)
  • MRI, CT, PET, ultrasound, and terahertz imaging for detection of urological diseases
  • Diagnostic endomicroscopy: OCT, CARS, SRS, FLIM, confocal fluorescence, multiphoton

    Advanced technology in urology
  • Novel designs and applications of optical fibers and endoscopic delivery devices
  • Robotic-assisted surgery including radical prostatectomy and nephrectomy
  • 3-D modeling and simulation on surgical procedures
  • Optical nerve stimulation for dysfunctional urinary systems
  • Nanoparticle-assisted and image-guided therapy

    BSC BEST PAPER AWARDS
    Boston Scientific, Corp. will sponsor the “BSC Best Paper Award” at this conference.

    Judging and Requirements
    Presentations and manuscripts will be judged based on scientific merit and potential clinical impact. Candidates for the award need to be the presenting author, a full-time student or resident in urology, must submit an extended technical summary (1~3 pages) of their best results at the time of Abstract submission, and must present their papers at the conference. Cash awards will be delivered after the publication of the conference proceedings volume.
  • Back to Top